These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 3041970

  • 1. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H, Murata S, Yabana H, Kikkawa K, Sugawara Y, Akimoto Y, Nagao T.
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M, Matsumura S, Masui M, Matsuura E, Kawakami M, Fujitomo H, Umeda T, Kagawa H, Hirohata S, Shima K.
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
    Morita T, Kanazawa T, Ito K, Nose T.
    Arzneimittelforschung; 1982 Dec; 32(9):1047-52. PubMed ID: 6890824
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R, Tagawa T, Ishida T, Naruse T.
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic effects of a new 1,5-benzothiazepine calcium antagonist on stroke in salt-loaded stroke-prone spontaneously hypertensive rats.
    Kikkawa K, Murata S, Iwasaki H, Toriumi W, Banno K, Nagao T.
    Arzneimittelforschung; 1992 Jun; 42(6):781-6. PubMed ID: 1418031
    [Abstract] [Full Text] [Related]

  • 6. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M, Iijima M, Ushijima T, Kajiwara Y, Kitabatake K.
    Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive effects of a new dihydropyridine calcium antagonist.
    Kimura Y, Fukui H, Tanaka M, Okamoto M, Morino A, Miura A, Kimura K, Enomoto H.
    Arzneimittelforschung; 1986 Sep; 36(9):1329-35. PubMed ID: 3790182
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A, Haruno A, Miyake H, Nagasaka M.
    J Cardiovasc Pharmacol; 1992 Sep; 20(5):723-30. PubMed ID: 1280733
    [Abstract] [Full Text] [Related]

  • 9. Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar Kyoto rats.
    Narita H, Nagao T, Yabana H, Yamaguchi I.
    J Pharmacol Exp Ther; 1983 Nov; 227(2):472-7. PubMed ID: 6631726
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs.
    Murata S, Kikkawa K, Yabana H, Nagao T.
    Arzneimittelforschung; 1988 Apr; 38(4):521-5. PubMed ID: 3401267
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y, Kishimoto T, Sunakawa K, Aoki K, Tanabe H, Takeshita T, Naruchi T.
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N.
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil.
    Hefti F, Clozel JP, Osterrieder W.
    Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242
    [Abstract] [Full Text] [Related]

  • 14. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
    Nakajima T, Shinohara T, Yaoka O, Fukunari A, Shinagawa K, Aoki K, Katoh A, Yamanaka T, Setoguchi M, Tahara T.
    J Pharmacol Exp Ther; 1992 May; 261(2):730-6. PubMed ID: 1578381
    [Abstract] [Full Text] [Related]

  • 15. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S, Takeyama K, Fukuya F, Nagai R, Hosoki K, Nishimura K, Deguchi T, Karasawa T.
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs.
    Sironi G, Montagna E, Greto L, Bianchi G, Leonardi A, Testa R.
    Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303
    [Abstract] [Full Text] [Related]

  • 17. Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries.
    Kikkawa K, Murata S, Nagao T.
    Arzneimittelforschung; 1988 Apr; 38(4):526-31. PubMed ID: 3165267
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative.
    Masuda Y, Takeguchi M, Arakawa C, Sakai T, Hibi M, Tanaka S, Shigenobu K, Kasuya Y.
    Arch Int Pharmacodyn Ther; 1990 Apr; 304():247-64. PubMed ID: 2241414
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive activity of cadralazine in experimental hypertensive rats.
    Takeyama K, Ikeno A, Minato H, Fukuya F, Nishimura S, Hosoki K, Kadokawa T.
    Arch Int Pharmacodyn Ther; 1988 Apr; 291():163-74. PubMed ID: 3365060
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M, Passoni A, Casciarri I, Bosetti P, Piazzoni L, Cazzulani P, Gandolfi CA, Tofanetti O, Ceserani R.
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.